Shattuck Labs, Inc.(STTK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

STTK Shattuck Labs, Inc.

交易中 12-19 09:59:08 EST

3.04

+0.08

+2.70%

最高3.09	最低3.01	成交量4,395
今开3.01	昨收2.96	日振幅2.70%
总市值1.92亿	流通市值7,341万	总股本6,328万
成交额1.33万	换手率0.02%	流通股本2,415万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"STTK","market":"US","secType":"STK","nameCN":"Shattuck Labs, Inc.","latestPrice":3.04,"timestamp":1766156344300,"preClose":2.96,"halted":0,"volume":4395,"delay":0,"floatShares":24148815,"shares":63279843,"eps":-0.975267,"marketStatus":"交易中","change":0.08,"latestTime":"12-19 09:59:08 EST","open":3.01,"high":3.09,"low":3.01,"amount":13290.627232499999,"amplitude":0.027027,"askPrice":3.07,"askSize":48,"bidPrice":2.99,"bidSize":121,"shortable":3,"etf":0,"ttmEps":-0.975267,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":2,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":2.96,"preHourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":2.96,"latestTime":"09:28 EST","volume":1,"amount":3.04,"timestamp":1766154480089},"postHourTrading":{"tag":"盘后","latestPrice":2.96,"preClose":2.96,"latestTime":"16:52 EST","volume":443,"amount":1316.08,"timestamp":1766094765512},"volumeRatio":0.231562,"impliedVol":0.8553,"impliedVolPercentile":0.12},"requestUrl":"/m/hq/s/STTK","defaultTab":"news","newsList":[{"id":"2586679822","title":"Shattuck Labs, Inc.盘中异动 临近午盘股价大涨5.47%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586679822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586679822?lang=zh_cn&edition=full","pubTime":"2025-11-27 00:52","pubTimestamp":1764175960,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日00时52分，Shattuck Labs, Inc.股票出现波动，股价急速拉升5.47%。截至发稿，该股报2.12美元/股，成交量5.6157万股，换手率0.09%，振幅6.72%。Shattuck Labs, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Shattuck Labs, Inc.公司简介：Shattuck Labs Inc是一家专门从事炎症和免疫介导疾病潜在治疗开发的生物技术公司。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112700524097810bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112700524097810bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"1175126239","title":"Shattuck Labs第三季度净收入为-1005.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175126239","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175126239?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:03","pubTimestamp":1763571802,"startTime":"0","endTime":"0","summary":"11月6日 - Shattuck Labs第三季度的合作收入为100万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STTK"],"gpt_icon":0},{"id":"2575254342","title":"Shattuck Labs, Inc.盘中异动 股价大涨5.43%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575254342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575254342?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:56","pubTimestamp":1760464568,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时56分，Shattuck Labs, Inc.股票出现异动，股价急速拉升5.43%。截至发稿，该股报1.94美元/股，成交量11.4023万股，换手率0.24%，振幅9.24%。Shattuck Labs, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Shattuck Labs, Inc.公司简介：Shattuck Labs Inc是一家专门从事炎症和免疫介导疾病潜在治疗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015015609a45ffc16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015015609a45ffc16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"1198755452","title":"Shattuck Labs Inc向SEC提交文件 申请转售股东持有的最多1.053亿股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1198755452","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198755452?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:08","pubTimestamp":1758226096,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc向美国证券交易委员会(SEC)提交申请文件，寻求转售股东持有的最多1.053亿股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STTK"],"gpt_icon":0},{"id":"2564326311","title":"美国OTC市场Ladrx Corp盘中异动 股价大跌9.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564326311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564326311?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:46","pubTimestamp":1756907171,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日21时46分，美国OTC市场Ladrx Corp股票出现波动，股价急速跳水9.22%。截至发稿，该股报1.28美元/股，成交量500股，换手率0.10%，振幅0.00%。美国OTC市场Ladrx Corp股票所在的生物技术行业中，整体涨幅为0.70%。美国OTC市场Ladrx Corp公司简介：CytRx Corp 在美国的医疗行业经营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903214611a4b1f304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903214611a4b1f304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4110","LADX","STTK","BK4139","LADR"],"gpt_icon":0},{"id":"1133794636","title":"Shattuck Labs宣布完成高达1.03亿美元私募配售并进行董事会任命","url":"https://stock-news.laohu8.com/highlight/detail?id=1133794636","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133794636?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:31","pubTimestamp":1756204285,"startTime":"0","endTime":"0","summary":"Shattuck Labs宣布完成高达1.03亿美元私募配售并进行董事会任命","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STTK","IRON"],"gpt_icon":0},{"id":"2560143037","title":"Shattuck Labs, Inc.8月18日成交额为45.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560143037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560143037?lang=zh_cn&edition=full","pubTime":"2025-08-19 15:29","pubTimestamp":1755588594,"startTime":"0","endTime":"0","summary":"美东时间2025年8月18日，Shattuck Labs, Inc.成交额为45.70万美元，成交额较昨日减少74.29%，当日成交量为45.72万股。Shattuck Labs, Inc.于2025年8月18日涨2.0%，报1.02美元，该股过去5个交易日涨38.02%，年初至今跌15.7%，过去60日跌4.67%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819153755a49146fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819153755a49146fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STTK"],"gpt_icon":0},{"id":"2558884611","title":"Shattuck Labs, Inc.8月11日成交额为29.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558884611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558884611?lang=zh_cn&edition=full","pubTime":"2025-08-12 14:54","pubTimestamp":1754981655,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Shattuck Labs, Inc.成交额为29.41万美元，成交额较昨日减少46.13%，当日成交量为38.74万股。Shattuck Labs, Inc.于2025年8月11日跌2.26%，报0.739美元，该股过去5个交易日跌0.51%，年初至今跌38.91%，过去60日跌18.32%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812145423a6e11248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812145423a6e11248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2558509860","title":"Shattuck Labs, Inc.8月8日成交额为54.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558509860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558509860?lang=zh_cn&edition=full","pubTime":"2025-08-09 14:54","pubTimestamp":1754722499,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Shattuck Labs, Inc.成交额为54.59万美元，成交额较昨日减少13.83%，当日成交量为71.12万股。Shattuck Labs, Inc.于2025年8月8日跌3.15%，报0.756美元，该股过去5个交易日涨3.32%，年初至今跌37.5%，过去60日跌21.3%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809145509a47e77eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809145509a47e77eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2557543482","title":"Shattuck Labs, Inc.8月7日成交额为63.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557543482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557543482?lang=zh_cn&edition=full","pubTime":"2025-08-08 14:51","pubTimestamp":1754635910,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Shattuck Labs, Inc.成交额为63.35万美元，成交额较昨日减少74.93%，当日成交量为78.47万股。Shattuck Labs, Inc.于2025年8月7日跌4.63%，报0.781美元，该股过去5个交易日涨2.48%，年初至今跌35.46%，过去60日跌21.2%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808145201a47c9c19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808145201a47c9c19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STTK"],"gpt_icon":0},{"id":"2557531428","title":"Shattuck Labs, Inc.8月6日成交额为252.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557531428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557531428?lang=zh_cn&edition=full","pubTime":"2025-08-07 14:43","pubTimestamp":1754549028,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Shattuck Labs, Inc.成交额为252.75万美元，成交额较昨日减少97.38%，当日成交量为295.19万股。Shattuck Labs, Inc.于2025年8月6日跌17.29%，报0.819美元，该股过去5个交易日涨6.48%，年初至今跌32.33%，过去60日跌13.63%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807144355a6d81df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807144355a6d81df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2557894323","title":"Shattuck Labs, Inc.8月5日成交额为9629.92万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557894323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557894323?lang=zh_cn&edition=full","pubTime":"2025-08-06 14:38","pubTimestamp":1754462334,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Shattuck Labs, Inc.成交额为9629.92万美元，成交额较昨日增加878702.44%，当日成交量为9419.97万股。Shattuck Labs, Inc.于2025年8月5日涨33.3%，报0.99美元，该股过去5个交易日涨18.56%，年初至今跌18.18%，过去60日涨5.32%。此外，该公司正在开发SL-425，这是SL-325的半衰期延长版本，以及多种其他基于dr3的临床前双特异性抗体，用于治疗IBD患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806143856a6d5f0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806143856a6d5f0f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2557316958","title":"万春医药盘中异动 下午盘股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557316958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557316958?lang=zh_cn&edition=full","pubTime":"2025-08-06 02:24","pubTimestamp":1754418254,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日02时24分，万春医药股票出现波动，股价急速下挫6.02%。截至发稿，该股报2.03美元/股，成交量6920股，换手率0.02%，振幅4.17%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为3.87%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806022414a4770ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806022414a4770ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","STTK"],"gpt_icon":0},{"id":"2557397044","title":"Arcutis Biotherapeutics, Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557397044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557397044?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:09","pubTimestamp":1754402959,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时09分，Arcutis Biotherapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.02%。其相关个股中，Y-Mabs Therapeutics, Inc.、Adaptimmune Therapeutics Plc、Shattuck Labs, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Shattuck Labs, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为169.73%、144.16%、102.87%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Bioxcel Therapeutics, Inc.、Shattuck Labs, Inc.，振幅分别为33.47%、28.35%、27.17%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805220919a6d4acd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805220919a6d4acd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139","ARQT"],"gpt_icon":0},{"id":"2557439084","title":"Nucana Plc盘中异动 早盘急速下跌5.03%报0.043美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557439084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557439084?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:02","pubTimestamp":1754402555,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时02分，Nucana Plc股票出现异动，股价急速下跌5.03%。截至发稿，该股报0.043美元/股，成交量3526.23万股，换手率9.24%，振幅14.44%。Nucana Plc股票所在的生物技术行业中，整体跌幅为2.89%。Nucana Plc公司简介：NuCana PLC是一家生物制药公司，专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药，旨在克服关键的抗癌机制，并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805220235973575a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805220235973575a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NCNA","STTK","BK4139"],"gpt_icon":0},{"id":"2557970433","title":"Cel-Sci Corporation盘中异动 早盘大幅跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557970433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557970433?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:01","pubTimestamp":1754402483,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时01分，Cel-Sci Corporation股票出现异动，股价大幅下跌5.84%。截至发稿，该股报8.71美元/股，成交量4.36万股，换手率0.85%，振幅8.43%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为2.99%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Bioxcel Therapeutics, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为135.21%、122.66%、95.92%，振幅较大的相关个股有Shattuck Labs, Inc.、Bioxcel Therapeutics, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为27.17%、26.77%、20.02%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522012397357506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522012397357506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","BK4139","STTK"],"gpt_icon":0},{"id":"2557975613","title":"Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)盘中异动 股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557975613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557975613?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:54","pubTimestamp":1754402041,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时54分，Seastar Medical Holding Corp C/Wts 28/10/2027 股票出现波动，股价急速拉升8.25%。截至发稿，该股报0.042美元/股，成交量1275股，换手率0.00%，振幅0.00%。Seastar Medical Holding Corp C/Wts 28/10/2027 股票所在的生物技术行业中，整体跌幅为2.94%。Seastar Medical Holding Corp C/Wts 28/10/2027 公司简介：SeaStar Medical Holding Corp 是一家医疗技术公司，开发专有解决方案，以减少过度炎症对重要器官的后果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805215401a6d4a6c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805215401a6d4a6c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","ICUCW","BK4139"],"gpt_icon":0},{"id":"2557139038","title":"木薯科学盘中异动 早盘股价大涨5.46%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557139038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557139038?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:51","pubTimestamp":1754401907,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时51分，木薯科学股票出现波动，股价大幅上涨5.46%。截至发稿，该股报2.42美元/股，成交量13.3284万股，换手率0.28%，振幅5.02%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为3.03%。目前，该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521514797356ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521514797356ff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAVA","BK4547","STTK","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2557397631","title":"Prothena Corporation Plc盘中异动 早盘快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557397631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557397631?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:50","pubTimestamp":1754401829,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时50分，Prothena Corporation Plc股票出现波动，股价快速拉升5.12%。截至发稿，该股报7.30美元/股，成交量19.3242万股，换手率0.36%，振幅7.93%。Prothena Corporation Plc股票所在的生物技术行业中，整体跌幅为3.08%。Prothena Corporation Plc公司简介：Prothena Corp PLC是一家临床生物技术公司，专注于蛋白质失调和具有改变破坏性神经退行性疾病以及罕见和周围淀粉样蛋白疾病进程潜力的研究性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805215029a6d4a53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805215029a6d4a53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00B19Z6F94.USD","BK4572","PRTA","LU1169589451.USD","LU1169590202.USD","AL","STTK","BK4104","IE0034390439.USD"],"gpt_icon":0},{"id":"2557739260","title":"Biovie Inc.盘中异动 股价大跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557739260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557739260?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:33","pubTimestamp":1754400803,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时33分，Biovie Inc.股票出现异动，股价急速下挫6.33%。截至发稿，该股报5.62美元/股，成交量3570股，换手率0.19%，振幅6.83%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为2.90%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521332394d1605f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521332394d1605f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139","STTK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shattucklabs.com","stockEarnings":[{"period":"1week","weight":-0.0836},{"period":"1month","weight":0.4726},{"period":"3month","weight":0.2982},{"period":"6month","weight":2.0933},{"period":"1year","weight":1.7407},{"period":"ytd","weight":1.4463}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Shattuck Labs, Inc.于2016年5月9日在特拉华州成立。该公司是一家创新的临床阶段生物技术公司，致力于开发双面融合蛋白作为一种全新的生物医学产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.170853},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049861},{"month":3,"riseRate":0.2,"avgChangeRate":-0.21466},{"month":4,"riseRate":0.8,"avgChangeRate":0.084733},{"month":5,"riseRate":0.2,"avgChangeRate":-0.177233},{"month":6,"riseRate":0.6,"avgChangeRate":-0.015781},{"month":7,"riseRate":0.2,"avgChangeRate":-0.098212},{"month":8,"riseRate":0.2,"avgChangeRate":-0.030277},{"month":9,"riseRate":0.2,"avgChangeRate":0.181582},{"month":10,"riseRate":0.2,"avgChangeRate":-0.168269},{"month":11,"riseRate":0.5,"avgChangeRate":-0.021423},{"month":12,"riseRate":1,"avgChangeRate":0.602238}],"exchange":"NASDAQ","name":"Shattuck Labs, Inc.","nameEN":"Shattuck Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shattuck Labs, Inc.(STTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Shattuck Labs, Inc.(STTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Shattuck Labs, Inc.,STTK,Shattuck Labs, Inc.股票,Shattuck Labs, Inc.股票老虎,Shattuck Labs, Inc.股票老虎国际,Shattuck Labs, Inc.行情,Shattuck Labs, Inc.股票行情,Shattuck Labs, Inc.股价,Shattuck Labs, Inc.股市,Shattuck Labs, Inc.股票价格,Shattuck Labs, Inc.股票交易,Shattuck Labs, Inc.股票购买,Shattuck Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shattuck Labs, Inc.(STTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Shattuck Labs, Inc.(STTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}